{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T13:33:55Z","timestamp":1751463235522,"version":"3.40.5"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T00:00:00Z","timestamp":1666828800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Roche Diagnostics KK"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Rapid diagnosis of influenza is critical in preventing the spread of infection and ensuring patients quickly receive antiviral medication to reduce the severity and duration of influenza symptoms, whilst controlling the spread of the causative virus. In Japan patients are often administered anti-influenza medication following a positive rapid antigen detection test (RADT) result. However, the sensitivity of RADTs can lead to false negative results. The cobas<jats:sup>\u00ae<\/jats:sup> Influenza A\/B Nucleic acid test for use on the cobas Liat<jats:sup>\u00ae<\/jats:sup> System (Liat) is a molecular point-of-care method that can provide a more sensitive alternative to RADTs for rapid influenza diagnosis and treatment.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>In this prospective multicenter study, diagnostic performance of the Liat test was compared with RADTs in patients presenting with influenza-like-illness. Test performance was also assessed by time since symptom onset.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Of 419 patients enrolled, 413 were evaluable for all designated tests. Most patients had type-A infection, and only one patient had influenza type B. In 413 patients, the sensitivity and specificity (95% CI) of the Liat test were 99.5% (97.2\u201399.9%) and 99.5% (97.4\u201399.9%), respectively, and were 79.7% (73.5\u201384.7%) and 95.4% (91.7\u201397.5%) for RADTs. For patients tested &lt;12 hours from symptom onset, the Liat test had significantly higher sensitivity than RADTs (p&lt;0.0001).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Overall, compared with standard of care RADTs, the Liat test was more sensitive and specific in children and adults, particularly in the early stages of infection. Greater sensitivity can enable earlier diagnosis and may better inform appropriate antiviral treatment decisions.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0276099","type":"journal-article","created":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T17:42:00Z","timestamp":1666892520000},"page":"e0276099","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparing the cobas Influenza A\/B Nucleic acid test for use on the cobas Liat System (Liat) with rapid antigen tests for clinical management of Japanese patients at the point of care"],"prefix":"10.1371","volume":"17","author":[{"given":"Hiroshige","family":"Mikamo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Yamagishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiro","family":"Asai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Miyazono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshikazu","family":"Shinbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiko","family":"Horie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Togashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1737-3228","authenticated-orcid":true,"given":"Elissa M.","family":"Robbins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuo","family":"Hirotsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2022,10,27]]},"reference":[{"key":"pone.0276099.ref001","unstructured":"World Health Organization. Influenza (seasonal) factsheet 2018 [updated 06\/11\/2018; cited 2022 February 23]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/influenza-(seasonal)."},{"issue":"1","key":"pone.0276099.ref002","doi-asserted-by":"crossref","first-page":"e54786","DOI":"10.1371\/journal.pone.0054786","article-title":"National surveillance of influenza-associated encephalopathy in Japan over six years, before and during the 2009\u20132010 influenza pandemic","volume":"8","author":"Y Gu","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"pone.0276099.ref003","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jcv.2012.10.007","article-title":"Severe form of encephalopathy associated with 2009 pandemic influenza A (H1N1) in Japan","volume":"56","author":"A Okumura","year":"2013","journal-title":"J Clin Virol"},{"issue":"1","key":"pone.0276099.ref004","doi-asserted-by":"crossref","first-page":"e024687","DOI":"10.1136\/bmjopen-2018-024687","article-title":"Incidence of hospitalisation for severe complications of influenza virus infection in Japanese patients between 2012 and 2016: a cross-sectional study using routinely collected administrative data","volume":"9","author":"H Yokomichi","year":"2019","journal-title":"BMJ open"},{"issue":"7","key":"pone.0276099.ref005","doi-asserted-by":"crossref","first-page":"512","DOI":"10.7326\/0003-4819-156-7-201204030-00411","article-title":"Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies","volume":"156","author":"J Hsu","year":"2012","journal-title":"Ann Intern Med"},{"issue":"2","key":"pone.0276099.ref006","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1046\/j.1442-200x.2000.01206.x","article-title":"Influenza surveillance system of Japan and acute encephalitis and encephalopathy in the influenza season","volume":"42","author":"N Okabe","year":"2000","journal-title":"Pediatr Int"},{"issue":"4","key":"pone.0276099.ref007","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s40506-016-0085-5","article-title":"Japanese surveillance systems and treatment for influenza","volume":"8","author":"H Zaraket","year":"2016","journal-title":"Current treatment options in infectious diseases"},{"issue":"7","key":"pone.0276099.ref008","doi-asserted-by":"crossref","first-page":"500","DOI":"10.7326\/0003-4819-156-7-201204030-00403","article-title":"Accuracy of rapid influenza diagnostic tests: a meta-analysis","volume":"156","author":"C Chartrand","year":"2012","journal-title":"Ann Intern Med"},{"issue":"6","key":"pone.0276099.ref009","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s10096-015-2328-7","article-title":"An algorithm to diagnose influenza infection: evaluating the clinical importance and impact on hospital costs of screening with rapid antigen detection tests","volume":"34","author":"M CP Gonz\u00e1lez-Del Vecchio","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"10","key":"pone.0276099.ref010","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00711-18","article-title":"Rapid antigen tests for influenza: rationale and significance of the FDA reclassification","volume":"56","author":"DA Green","year":"2018","journal-title":"J Clin Microbiol"},{"issue":"5","key":"pone.0276099.ref011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231217","article-title":"Very high sensitivity of a rapid influenza diagnostic test in adults and elderly individuals within 48 hours of the onset of illness","volume":"15","author":"Y Seki","year":"2020","journal-title":"PloS One"},{"issue":"9","key":"pone.0276099.ref012","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1086\/597828","article-title":"Low sensitivity of rapid diagnostic test for influenza","volume":"48","author":"TM Uyeki","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"8","key":"pone.0276099.ref013","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1086\/656408","article-title":"Early oseltamivir treatment of influenza in children 1\u20133 years of age: a randomized controlled trial","volume":"51","author":"S Heinonen","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"1","key":"pone.0276099.ref014","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jcv.2014.01.016","article-title":"Rapid influenza diagnostic test use and antiviral prescriptions in outpatient settings pre- and post-2009 H1N1 pandemic","volume":"60","author":"LO Williams","year":"2014","journal-title":"J Clin Virol"},{"key":"pone.0276099.ref015","unstructured":"The Japanese Association for Infectious Diseases. Recommendations of the Japanese society of infectious diseases\u2014use of anti-influenza drugs 2019 [cited 2022 February 23]. Available from: https:\/\/www.kansensho.or.jp\/modules\/guidelines\/index.php?content_id=37."},{"issue":"3","key":"pone.0276099.ref016","doi-asserted-by":"crossref","first-page":"E55","DOI":"10.1111\/j.1469-0691.2011.03753.x","article-title":"Changes in epidemiology, clinical features and severity of influenza A (H1N1) 2009 pneumonia in the first post-pandemic influenza season","volume":"18","author":"D Viasus","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"pone.0276099.ref017","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s10156-011-0288-0","article-title":"Widespread use of neuraminidase inhibitors in Japan","volume":"17","author":"N. Sugaya","year":"2011","journal-title":"J Infect Chemother"},{"key":"pone.0276099.ref018","unstructured":"Centers for Disease Control and Prevention. Information on rapid molecular assays, RT-PCR, and other molecular assays for diagnosis of influenza virus infection 2019 [cited 2021 September 17]. Available from: https:\/\/www.cdc.gov\/flu\/professionals\/diagnosis\/molecular-assays.htm."},{"issue":"Suppl 7","key":"pone.0276099.ref019","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jiac.2015.12.019","article-title":"JAID\/JSC Guidelines for the Treatment of Respiratory Infectious Diseases: The Japanese Association for Infectious Diseases\/Japanese Society of Chemotherapy\u2014The JAID\/JSC Guide to Clinical Management of Infectious Disease\/Guideline-preparing Committee Respiratory Infectious Disease WG","volume":"22","author":"K Mikasa","year":"2016","journal-title":"J Infect Chemother"},{"issue":"11","key":"pone.0276099.ref020","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1093\/jac\/dkx271","article-title":"Safety and effectiveness of neuraminidase inhibitors for influenza treatment, prophylaxis, and outbreak control: a systematic review of systematic reviews and\/or meta-analyses","volume":"72","author":"MK Doll","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"pone.0276099.ref021","unstructured":"Food and Drug Administration. FDA Decision Summary KT191729: cobas Influenza A\/B Nucleic acid test for use on the cobas liat system 2019 [cited 2022 February 23]. Available from: https:\/\/www.accessdata.fda.gov\/cdrh_docs\/reviews\/K191729.pdf."},{"key":"pone.0276099.ref022","unstructured":"Roche Diagnostics. cobas\u00ae Influenza A\/B Nucleic acid test for use on the cobas\u00ae Liat\u00ae System [package insert]. Roche Molecular Systems, Inc. 2018."},{"issue":"7","key":"pone.0276099.ref023","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1093\/cid\/ciz056","article-title":"Rapid molecular tests for influenza, respiratory syncytial virus, and other respiratory viruses: a systematic review of diagnostic accuracy and clinical impact studies","volume":"69","author":"LM Vos","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"1","key":"pone.0276099.ref024","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/cid\/ciy837","article-title":"The clinical utility of point-of-care tests for influenza in ambulatory care: a systematic review and meta-analysis","volume":"69","author":"JJ Lee","year":"2019","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"key":"pone.0276099.ref025","article-title":"The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, China","author":"Q Ding","year":"2020","journal-title":"J Med Virol"},{"key":"pone.0276099.ref026","unstructured":"US Food and Drug Administration. Statistical guidance on reporting results from studies evaluating diagnostic tests 2007 [cited 2019 August 19]. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/statistical-guidance-reporting-results-studies-evaluating-diagnostic-tests-guidance-industry-and-fda."},{"issue":"3","key":"pone.0276099.ref027","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.diagmicrobio.2016.03.015","article-title":"Variability in the diagnostic performance of a bedside rapid diagnostic influenza test over four epidemic seasons in a pediatric emergency department","volume":"85","author":"E Avril","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"3","key":"pone.0276099.ref028","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.diagmicrobio.2016.11.015","article-title":"Contribution of a rapid influenza diagnostic test to manage hospitalized patients with suspected influenza","volume":"87","author":"L Busson","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"9","key":"pone.0276099.ref029","doi-asserted-by":"crossref","first-page":"846","DOI":"10.11150\/kansenshogakuzasshi1970.78.846","article-title":"Appropriate use of rapid diagnostic testing for influenza","volume":"78","author":"A Hata","year":"2004","journal-title":"Kansenshogaku Zasshi"},{"issue":"1","key":"pone.0276099.ref030","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/MOP.0b013e328341ebd9","article-title":"Diagnostic tests for influenza infection","volume":"23","author":"ML Landry","year":"2011","journal-title":"Curr Opin Pediatr"},{"issue":"1","key":"pone.0276099.ref031","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1186\/s12889-020-08603-x","article-title":"The characteristics of influenza-like illness management in Japan","volume":"20","author":"S Tsuzuki","year":"2020","journal-title":"BMC Public Health"},{"issue":"3","key":"pone.0276099.ref032","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01611-19","article-title":"Comparison of the ID Now influenza A & B 2, cobas influenza A\/B, and Xpert Xpress Flu point-of-care nucleic acid amplification tests for influenza A\/B virus detection in children","volume":"58","author":"N Kanwar","year":"2020","journal-title":"J Clin Microbiol"},{"issue":"5","key":"pone.0276099.ref033","doi-asserted-by":"crossref","first-page":"e0216308","DOI":"10.1371\/journal.pone.0216308","article-title":"Diagnostic accuracy of a rapid RT-PCR assay for point-of-care detection of influenza A\/B virus at emergency department admission: a prospective evaluation during the 2017\/2018 influenza season","volume":"14","author":"M Maignan","year":"2019","journal-title":"PLoS One"},{"issue":"3","key":"pone.0276099.ref034","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1373\/jalm.2018.028639","article-title":"Assay integrity of a PCR influenza point-of-care test remains following artificial system contamination","volume":"4","author":"JE Phillips","year":"2019","journal-title":"J Appl Lab Med"},{"issue":"2","key":"pone.0276099.ref035","article-title":"Comparison of three rapid influenza diagnostic tests with digital readout systems and one conventional rapid influenza diagnostic test","volume":"32","author":"SW Ryu","year":"2018","journal-title":"J Clin Lab Anal"},{"issue":"2","key":"pone.0276099.ref036","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S1473-3099(13)70267-6","article-title":"Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial","volume":"14","author":"AM Fry","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"pone.0276099.ref037","unstructured":"World Health Organization. Antimicrobial resistance 2021 [cited 2022 23 February]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antimicrobial-resistance."},{"issue":"1","key":"pone.0276099.ref038","doi-asserted-by":"crossref","DOI":"10.3390\/ph15010028","article-title":"Baloxavir marboxil: an original new drug against fnfluenza","volume":"15","author":"F. Dufrasne","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"issue":"13","key":"pone.0276099.ref039","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1056\/NEJM199709253371302","article-title":"Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections","volume":"337","author":"FG Hayden","year":"1997","journal-title":"N Engl J Med"},{"issue":"5","key":"pone.0276099.ref040","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/00006454-200005000-00005","article-title":"Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial","volume":"19","author":"JA Hedrick","year":"2000","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"pone.0276099.ref041","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1086\/314904","article-title":"Efficacy and safety of the neuraminidase inhibitor zanamivirin in the treatment of influenza A and B virus infections","volume":"180","author":"AS Monto","year":"1999","journal-title":"J Infect Dis"},{"issue":"8","key":"pone.0276099.ref042","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/jama.283.8.1016","article-title":"Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group","volume":"283","author":"JJ Treanor","year":"2000","journal-title":"JAMA"},{"issue":"7","key":"pone.0276099.ref043","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3851\/IMP2874","article-title":"Single dose peramivir for the treatment of acute seasonal influenza: integrated analysis of efficacy and safety from two placebo-controlled trials","volume":"20","author":"R Whitley","year":"2015","journal-title":"Antivir Ther"},{"issue":"2","key":"pone.0276099.ref044","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00006454-200102000-00002","article-title":"Oral oseltamivir treatment of influenza in children","volume":"20","author":"RJ Whitley","year":"2001","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"pone.0276099.ref045","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3122\/jabfm.2019.02.180183","article-title":"Impact of a rapid point of care test for influenza on guideline consistent care and antibiotic use","volume":"32","author":"AP Dale","year":"2019","journal-title":"J Am Board Fam Med"},{"key":"pone.0276099.ref046","unstructured":"Roche Diagnostics. cobas\u00ae SARS-CoV-2 & Influenza A\/B Nucleic acid test for use on the cobas\u00ae Liat\u00ae System [package insert]. Roche Molecular Systems, Inc. 2020;(v2.0)."},{"key":"pone.0276099.ref047","unstructured":"Roche Diagnostics. cobas\u00ae Influenza A\/B & RSV Nucleic acid test for use on the cobas\u00ae Liat\u00ae System [package insert]. Roche Molecular Systems, Inc. 2019."},{"issue":"1","key":"pone.0276099.ref048","doi-asserted-by":"crossref","first-page":"e0109021","DOI":"10.1128\/spectrum.01090-21","article-title":"Evaluation of the Alinity m Resp-4-Plex Assay for the detection of severe acute respiratory syndrome coronavirus 2, influenza A virus, influenza B virus, and respiratory syncytial virus","volume":"10","author":"W Zhen","year":"2022","journal-title":"Microbiol Spectr"},{"key":"pone.0276099.ref049","unstructured":"National Institute of Infectious Diseases. Isolation\/detection of influence virus in Japan, 2018\/19 season 2018 [cited 2022 February 02]. Available from: https:\/\/www.niid.go.jp\/niid\/images\/iasr\/arc\/gv\/1819\/data1819.1j.pdf."},{"key":"pone.0276099.ref050","unstructured":"National Institute of Infectious Diseases Japan. Infectious Disease Surveillance Center: Influenza level pandemic map 2018 [cited 2022 February 02]. Available from: https:\/\/nesid4g.mhlw.go.jp\/Hasseidoko\/Levelmap\/flu\/2018_2019\/trend.html."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0276099","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T17:42:49Z","timestamp":1666892569000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0276099"}},"subtitle":[],"editor":[{"given":"Benjamin M.","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,10,27]]},"references-count":50,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0276099","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2022,10,27]]}}}